News items Vici-beurs voor Maroeska Rovers
23 February 2018

Maroeska Rovers, Professor of Evidence Based Surgery, will receive a Vici research grant of 1.5 million euros from NWO (Netherlands Organisation for Scientific Research).

Over the next five years, the researchers can use this money to perform their research and build their own research groups. The Vici grant is one of the largest individual scientific prizes in the Netherlands. This year, the NWO awarded 35 Vici grants in total.

Maroeska Rovers is Professor of Evidence-based Surgery at Radboud university medical center, within the theme of Urological cancers. It is her ambition to contribute to the development of effective, affordable, and valuable surgical innovations.
 
Rovers will use her Vici grant to perform research with the aim of developing better methods to evaluate surgical innovations as early as possible. Currently, this evaluation takes place when these innovations have largely been developed and marketed. Up to half of the innovations do not add any value which results in a waste of healthcare costs in Europe. According to Rovers, new medical tools should already be evaluated for added value for patients as early as the very first concept. She intends to develop, test, and validate methods for this.

 

Related news items


Experiences with molecular tumor boards

18 June 2019

In British Journal of Cancer Annelieke Willemsen, Carla van Herpen and colleagues showed that MTBs may have an important impact on patient care, but challenges remain for the accessibility for cancer patients.

read more

Internal KWF review procedure 2020

13 June 2019

In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more

Peter van der Kraan new theme leader Inflammatory diseases

13 June 2019

It is our pleasure to introduce Peter van der Kraan from the Dept. of Rheumatology, as the new leader of our theme Inflammatory diseases. As such he will be the successor of Irma Joosten who has done an outstanding job in the last years as theme leader, for which we thank her wholeheartedly.

read more

RIHS PhD candidates visit Philips Healthcare

13 June 2019

On 7 June the RIHS PhD council organized an excursion to Philips Healthcare in Best.

read more

Intake of a reduced dose of pazopanib with food the effect on pharmacokinetics, patient safety and preference

13 June 2019

In Clinical Pharmacology & Therapeutics Floor Lubberman and colleagues showed that the intake of 600mg pazopanib with food resulted in a bioequivalent exposure and was preferred over a standard pazopanib dose without food.

read more

Developing malaria gametocytes under attack

6 June 2019

In Science Translational Medicine, researchers from the group of Teun Bousema and international colleagues have revealed previously unknown targets of natural human antibody responses that are found on the surfaces of red blood cells infected with malaria parasites.

read more